Your email has been successfully added to our mailing list.

×
0 0 0.0119760479041916 0.0119760479041916 0.0196407185628742 0.0250898203592813 0.0179640718562874 0
Stock impact report

BioAffinity Technologies Shares Rise 8% After Getting Notice to Allow U.S. Patent [MarketWatch]

bioAffinity Technologies, Inc. (BIAF) 
Company Research Source: MarketWatch
Patent and Trademark Office has provided a Notice of Allowance for a patent application for the targeted delivery of novel cancer treatments. A Notice of Allowance is issued after the USPTO makes a determination that a patent should be granted for the claimed invention. The U.S. patent, titled "Porphyrin Compounds and Compositions Useful for Treating Cancer," will be issued to the company's wholly owned OncoSelect subsidiary and grant protection to 2037. BioAffinity Technologies shares hit their 52-week low of $1.31 on Dec. 30, and are down 43% in the past three months. Write to Chris Wack at chris.wack@wsj.com Show less Read more
Impact Snapshot
Event Time:
BIAF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BIAF alerts

from News Quantified
Opt-in for
BIAF alerts

from News Quantified